ProRx's oral NAD+ is offered in a 1 mL daily-use ampule, compounded under strict USP <795> and cGMP standards in the company's FDA-registered 503B facility. Each batch undergoes third-party potency, ...

ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...

So we were immediately intrigued when she launched her own skincare line, Elm Biosciences, in late 2025 with two products: ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Antibiotic factories release resistance genes at levels 100x higher than city sewage. Pharmaceutical pollution is fueling ...

This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and ...